Literature DB >> 9609587

Cocaine augments contractility of the pregnant human uterus by both adrenergic and nonadrenergic mechanisms.

W W Hurd1, A L Betz, M P Dombrowski, V P Fomin.   

Abstract

OBJECTIVE: Our purpose was to evaluate the mechanisms of cocaine's effect on both spontaneous and agonist-induced contractility of pregnant human myometrium. STUDY
DESIGN: Myometrium was obtained from 42 women at term who were undergoing cesarean section. Myometrial strips were suspended in contraction baths and isometric contractions were measured. Tissue was exposed to various combinations of cocaine, prazosin, desipramine, benzoylecgonine, and procaine. Spontaneous contractility and the contractile responses to increasing concentrations of methoxamine and oxytocin were measured and compared.
RESULTS: Cocaine increased spontaneous myometrial contractility by more than threefold. Prazosin, an alpha-adrenergic antagonist, blocked this effect only for the first 35 minutes of exposure. The cumulative concentration-response to the alpha-adrenergic agonist methoxamine was increased by cocaine in terms of both sensitivity and maximal response. The maximal response to oxytocin, but not the sensitivity, was increased by cocaine by an effect that could not be blocked by prazosin.
CONCLUSION: Cocaine augments spontaneous and agonist-induced contractility of pregnant human myometrium by mechanisms that appear to be both alpha-adrenergic and nonadrenergic in nature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609587     DOI: 10.1016/s0002-9378(98)70551-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Mode of Delivery in Drug-Dependent Pregnant Women: A Case Control Study.

Authors:  Ana Raquel Neves; Fabiane Neves; Isabel Santos Silva; Maria do Céu Almeida; Pitorra Monteiro
Journal:  J Pregnancy       Date:  2017-02-26

2.  Uterine contractility changes in a perfused swine uterus model induced by local anesthetics procaine, lidocaine, and ropivacaine.

Authors:  Fabian Weinschenk; Ralf Dittrich; Andreas Müller; Laura Lotz; Matthias W Beckmann; Stefan W Weinschenk
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.